Enavogliflozin
| Enavogliflozin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Enavogliflozin is a medication used in the management of type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which work by preventing the kidneys from reabsorbing glucose back into the blood, thereby lowering blood sugar levels.
Mechanism of Action[edit]
Enavogliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the proximal tubules of the kidney. This inhibition reduces the reabsorption of glucose from the renal filtrate, leading to increased glucose excretion in the urine and a reduction in blood glucose levels.
Indications[edit]
Enavogliflozin is indicated for the treatment of type 2 diabetes in adults. It is often prescribed when diet and exercise alone do not provide adequate glycemic control. It may be used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin.
Side Effects[edit]
Common side effects of enavogliflozin include:
- Urinary tract infections
- Genital mycotic infections
- Increased urination
- Hypotension
Serious but less common side effects may include:
- Ketoacidosis
- Acute kidney injury
- Hypoglycemia (when used with insulin or sulfonylureas)
Contraindications[edit]
Enavogliflozin is contraindicated in patients with:
- Severe renal impairment
- End-stage renal disease
- Hypersensitivity to the drug or its components
Pharmacokinetics[edit]
Enavogliflozin is administered orally and has a bioavailability of approximately __%. It is primarily metabolized in the liver and has an elimination half-life of __ hours. The drug is excreted mainly through the urine.
Research and Development[edit]
Enavogliflozin is currently undergoing various clinical trials to evaluate its efficacy and safety in different populations and in combination with other antidiabetic medications.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
